Download the New Age of Decentralized Clinical Trials
There has been substantial attention paid to, and emphasis on, DCT lately. Despite the explosion in interest among sponsors, CROs, and tech providers, the reality is that there remains much more to explore and understand relative to the feasibility of new approaches, the technologies and capabilities needed to support DCT, and how DCT impacts trial design, trial management, data collection, and analysis.
Much of the focus is on the more common elements, such as those focused on electronic informed consent, eCOA, and telemedicine. This paper will dive deep into these topics and the best practices for managing these complex trials.
At Astrix, we take a structured, outcome-driven approach to clinical technology services. Our services are designed to help life sciences organizations accelerate study execution, ensure regulatory compliance, and maximize the value of clinical data.
With decades of experience across clinical operations, data management, AI and digital platforms, we align technology strategy with the realities of modern clinical trials – complex protocols, decentralized models, and increasing data volumes.
Our clinical technology services help streamline workflows and automate manual tasks, reducing cycle times in clinical research and operations. By integrating advanced platforms and data systems, organizations can accelerate study setup, monitoring, and reporting—ultimately shortening development timelines and lowering operational friction.
